rs7305099 — WNK1 WNK1 intronic variant

Intronic WNK1 variant where the G allele is associated with increased essential hypertension risk while the minor T allele is protective; WNK1 is the master kinase controlling renal sodium-chloride reabsorption through the NCC cotransporter

See your personal result for WNK1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

WNK1 rs7305099 — Your Kidney's Blood Pressure Thermostat

Blood pressure is ultimately a plumbing problem: the kidneys decide how much salt to keep and how much to excrete, and that decision sets the volume — and thus the pressure — of your blood. At the center of that decision is WNK1, a serine-threonine kinase expressed throughout the kidney's distal nephron that acts as a master switch for renal salt handling11 WNK1, a serine-threonine kinase expressed throughout the kidney's distal nephron that acts as a master switch for renal salt handling
WNK stands for "with no lysine" — the kinase lacks a conserved lysine residue that most kinases use for catalysis, making it structurally unusual. The rs7305099 variant sits within an intron of WNK1 on chromosome 12, tagging a haplotype block that affects WNK1 expression and activity in the kidney. Its G allele is more common globally and is associated with elevated essential hypertension risk, while the minor T allele is protective.

The Mechanism

WNK1 controls blood pressure by regulating the NaCl cotransporter (NCC)22 NaCl cotransporter (NCC)
NCC is the main sodium-chloride transporter in the distal convoluted tubule of the kidney; its activity directly determines how much sodium is reabsorbed versus excreted in urine in the kidney's distal convoluted tubule. Active WNK1 phosphorylates two intermediate kinases — SPAK and OSR1 — which then phosphorylate and activate NCC, increasing sodium reabsorption. More NCC activity means more salt retained, higher blood volume, and higher blood pressure.

The elegant regulatory feature of this system is its potassium-sensing capacity. When dietary potassium is adequate, intracellular chloride rises in distal tubule cells, directly inhibiting WNK1 kinase activity and allowing more sodium to be excreted. When potassium intake is low, chloride falls, WNK1 activates, NCC is phosphorylated, and sodium retention rises — an evolutionary adaptation to potassium-poor environments that becomes hypertension-promoting in modern high-sodium, low-potassium diets.

A rare but instructive clinical example: large intron 1 deletions in WNK1 that increase WNK1 expression cause Gordon's syndrome (pseudohypoaldosteronism type II)33 Gordon's syndrome (pseudohypoaldosteronism type II)
characterized by hypertension, high potassium, and metabolic acidosis — a naturally occurring experiment showing what too much WNK1 activity does to blood pressure. The rs7305099 variant is not a deletion, but its haplotype-level effects on WNK1 expression likely operate through the same NCC-mediated mechanism at smaller scale.

The Evidence

The direct association evidence for rs7305099 comes from a case-control study in 476 hypertensive and 491 normotensive Northern Han Chinese participants44 case-control study in 476 hypertensive and 491 normotensive Northern Han Chinese participants
Liu et al. 2023, Frontiers in Genetics; 12 WNK1 tag SNPs were tested; rs7305099 survived Bonferroni correction. The T allele was significantly protective against essential hypertension: OR 0.627 (95% CI 0.491–0.801; p<0.0002) in the allele model, with homozygous TT carriers showing strikingly lower risk (OR 0.278, 95% CI 0.140–0.552). This is one population study, so the evidence is moderate rather than strong — but it sits within a well-established biological framework where multiple WNK1 variants across independent cohorts consistently associate with blood pressure variation.

Broader WNK1 variant evidence supports the framework: Newhouse et al. 200955 Newhouse et al. 2009
PLoS One; 1,700 hypertensive cases + 1,700 controls in BRIGHT study, replicated in 17,851 participants across 6 populations showed that the WNK1 intron 1 variant rs765250 (in the same gene region) raises systolic BP by 3.14 mmHg (95% CI 1.23–4.9) — a clinically meaningful effect size for a common variant. Tobin et al. 200566 Tobin et al. 2005 demonstrated that WNK1 haplotypes can shift ambulatory blood pressure by >10 mmHg in some carrier groups, and Tobin et al. 200877 Tobin et al. 2008 followed 5,326 children and found WNK1 variants associate with the rate of diastolic blood pressure increase across childhood — suggesting WNK1 variation shapes the developmental trajectory of blood pressure, not just adult phenotype.

Practical Actions

The WNK1-NCC-blood pressure axis has a well-understood dietary leverage point: potassium intake. Because intracellular chloride (which inhibits WNK1) tracks plasma potassium, adequate dietary potassium directly damps WNK1 activity in the distal nephron. For G allele carriers — especially GG homozygotes — who have higher baseline WNK1-NCC activation, ensuring potassium intake reaches the recommended 3,500–4,700 mg daily from food is the most targeted dietary intervention. This is not generic dietary advice: the mechanism is specific to WNK1 biology and operates differently for people with WNK1 risk variants than for those with normal WNK1 function.

Sodium intake amplifies the risk: the WNK1-NCC system is the molecular substrate of salt-sensitive hypertension. Reducing dietary sodium below 2,300 mg daily reduces NCC substrate availability, partially offsetting higher WNK1-driven transporter activity. Monitoring home blood pressure periodically provides an objective measure of whether the WNK1-related sodium retention is expressing in practice.

Interactions

rs7305099 is one of 12 tag SNPs in WNK1 studied by Liu et al.; it is in the same gene region as rs765250 (intron 1) and rs1012729, though their linkage disequilibrium relationships are not fully characterized across populations. The haplotype A-A-A-C-G-G-G identified in the same study was associated with increased hypertension susceptibility (OR 1.23, p=0.043), suggesting rs7305099 may be part of a broader hypertension-risk haplotype.

WNK1 variants interact biologically with potassium intake (via the chloride-sensing mechanism) and with sodium intake (salt sensitivity). No specific compound genotype interaction with another GeneOps SNP has been published, but the AGT (angiotensinogen) variants rs699 and rs4762, also in the renin-angiotensin system, operate on the same blood pressure output and may compound with WNK1 variation in individuals with multiple risk alleles across these pathways.

Nutrient Interactions

sodium altered_metabolism
potassium increased_need

Genotype Interpretations

What each possible genotype means for this variant.

TT Protective Genotype Beneficial

Two protective T alleles — lowest hypertension risk at this locus; WNK1-NCC signaling most attenuated

You carry two copies of the minor T allele at rs7305099, the genotype with the lowest hypertension risk at this locus. About 15.7% of people globally carry this genotype, with somewhat higher frequency in those of African ancestry (~25%) and lower frequency in East Asians (~6%). Both T alleles attenuate WNK1 kinase signaling in the kidney's distal nephron, reducing NCC-mediated sodium reabsorption and lowering the genetic contribution to blood pressure elevation from this locus. In Liu et al. 2023, TT carriers had an odds ratio of 0.278 (95% CI 0.140–0.552) for essential hypertension compared to GG carriers — roughly a 3.6-fold lower odds — after Bonferroni correction.

GT Intermediate Hypertension Risk Intermediate

One G allele, one protective T allele — intermediate hypertension risk, partial WNK1 attenuation

You carry one G allele (risk) and one T allele (protective), the most common genotype globally (about 48% of people). Your WNK1 kinase activity at this locus falls between GG and TT carriers — one T allele partially reduces WNK1-NCC signaling relative to GG homozygotes, but you don't have full bilateral attenuation. In the Liu et al. 2023 dataset, T allele carriers (including GT) showed significantly lower hypertension risk (OR 0.627 per T allele), meaning your one T allele provides meaningful but incomplete protection compared to two T alleles.

GG Elevated Hypertension Risk High Risk

Both G alleles — highest hypertension risk at this locus; WNK1-mediated sodium retention most active

The GG genotype represents the highest-expression WNK1 signaling state at this locus. WNK1's activated SPAK/OSR1 cascade phosphorylates NCC constitutively at higher levels, increasing distal tubular sodium reabsorption and expanding plasma volume. Over time this chronically elevates blood pressure, a process exacerbated by low dietary potassium (which further activates WNK1 via the chloride-sensing mechanism) and amplified by high sodium intake (which provides more substrate for the upregulated transporter).

The rarity of TT carriers means GG homozygotes make up the majority of the population; this variant contributes to overall population blood pressure distribution rather than marking a small high-risk minority. Lifestyle, diet, and other genetic factors (AGT, ACE, AGTR1 variants, etc.) all modify how much the WNK1 GG genotype expresses as elevated blood pressure in practice.